PAVmed Inc. Income Statement
PAVM|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
PAVmed Inc. reported $3M in revenue and $40M in net income for FY2025. Revenue has grown at a 56.4% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.0M | $3.0M | $2.5M | $500.0K | $500.0K |
| Cost of Revenue | $4.8M | $6.4M | $3.6M | $585.0K | $585.0K |
| Gross Profit | - | - | - | - | -$85.0K |
| SG&A Expense | $24.5M | $30.9M | $41.4M | $25.4M | $9.6M |
| R&D Expense | $5.9M | $14.3M | $25.3M | $19.8M | $11.0M |
| Operating Income | -$44.5M | -$68.8M | -$91.1M | -$54.4M | -$23.4M |
| Interest Expense | - | $589.0K | $1.3M | $1.3M | $53.0K |
| Income Tax | $0 | - | - | - | - |
| Net Income | $39.8M | -$64.2M | -$89.0M | -$50.3M | -$34.3M |
| EPS (Basic) | $99.15 | -$9.16 | -$15.03 | -$0.65 | - |
| EPS (Diluted) | $14.90 | -$9.16 | -$15.03 | - | -$0.72 |
| Shares Outstanding | 373.3K | 8.6M | 6.3M | 86.4M | 63.8M |
| Gross Margin | - | - | - | - | -17.0% |
| Operating Margin | -1485.4% | -2293.2% | -3643.5% | -10878.6% | -4670.2% |
| Profit Margin | 1328.6% | -2139.2% | -3559.3% | -10069.4% | -6855.2% |